Role of vascular calcification inhibitors in preventing vascular dysfunction and mortality in hemodialysis patients

Creative Commons License

Gungor O., KOÇYİĞİT I., YILMAZ M. I., Sezer S.

SEMINARS IN DIALYSIS, vol.31, no.1, pp.72-81, 2018 (SCI-Expanded) identifier

  • Publication Type: Article / Review
  • Volume: 31 Issue: 1
  • Publication Date: 2018
  • Doi Number: 10.1111/sdi.12616
  • Journal Name: SEMINARS IN DIALYSIS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.72-81
  • Erciyes University Affiliated: Yes

Abstract

Cardiovascular events make up the primary cause of death in hemodialysis patients, and the risk for cardiovascular mortality is significantly increased by vascular calcification, a condition observed frequently in this patient population. The mechanisms underlying the pathogenesis of vascular calcification are complex, and many factors facilitate or hinder the development of calcification. In this review, we first summarize the main factors contributing to the pathogenesis of vascular calcification in patients with end-stage renal disease. We then explore the role of calcification inhibitors in the calcification process, as well as their effect on vascular dysfunction and mortality in hemodialysis patients.